Open Access

[Retracted] MicroRNA‑181 serves an oncogenic role in breast cancer via the inhibition of SPRY4

  • Authors:
    • Yifu Tian
    • Xiaodan Fu
    • Qingling Li
    • Ying Wang
    • Dan Fan
    • Qin Zhou
    • Weilu Kuang
    • Liangfang Shen
  • View Affiliations

  • Published online on: March 4, 2022     https://doi.org/10.3892/mmr.2022.12673
  • Article Number: 157
  • Copyright : © Tian et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Mol Med Rep 18: [Related article:] 5603–5613, 2018; DOI: 10.3892/mmr.2018.9572

Following the publication of this paper, it was drawn to the Editors’ attention by a concerned reader that the Transwell cell migration assay data shown in Figs. 3B and 9B were strikingly similar to data appearing in different form in other articles by different authors. Owing to the fact that the contentious data in the above article had already been published elsewhere, or were already under consideration for publication, prior to its submission to Molecular Medicine Reports, the Editor has decided that this paper should be retracted from the Journal. After having been in contact with the authors, they agreed with the decision to retract the paper. The Editor apologizes to the readership for any inconvenience caused.

Related Articles

Journal Cover

May-2022
Volume 25 Issue 5

Print ISSN: 1791-2997
Online ISSN:1791-3004

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Tian Y, Fu X, Li Q, Wang Y, Fan D, Zhou Q, Kuang W and Shen L: [Retracted] MicroRNA‑181 serves an oncogenic role in breast cancer via the inhibition of SPRY4. Mol Med Rep 25: 157, 2022
APA
Tian, Y., Fu, X., Li, Q., Wang, Y., Fan, D., Zhou, Q. ... Shen, L. (2022). [Retracted] MicroRNA‑181 serves an oncogenic role in breast cancer via the inhibition of SPRY4. Molecular Medicine Reports, 25, 157. https://doi.org/10.3892/mmr.2022.12673
MLA
Tian, Y., Fu, X., Li, Q., Wang, Y., Fan, D., Zhou, Q., Kuang, W., Shen, L."[Retracted] MicroRNA‑181 serves an oncogenic role in breast cancer via the inhibition of SPRY4". Molecular Medicine Reports 25.5 (2022): 157.
Chicago
Tian, Y., Fu, X., Li, Q., Wang, Y., Fan, D., Zhou, Q., Kuang, W., Shen, L."[Retracted] MicroRNA‑181 serves an oncogenic role in breast cancer via the inhibition of SPRY4". Molecular Medicine Reports 25, no. 5 (2022): 157. https://doi.org/10.3892/mmr.2022.12673